StarZero All shows Try the podcast clipper →

Aug 16, 2024 · 38m · sourcery

The Quiet Revolution in DNA Sequencing | Nucleus Genomics · Sourcery with Molly O'Shea

Kian Sadeghi · 25m spoken Molly O'Shea · 7m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this episode of Sourcery, host Molly O'Shea interviews Kian Sadeghi, founder and CEO of Nucleus Genomics, about how affordable whole genome sequencing is revolutionizing consumer healthcare. They discuss the launch of Nucleus IQ, the ethics of direct-to-consumer genetic data, and the technological evolution making comprehensive genomic analysis accessible to all.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Molly holds 21.2% of the talking time here. How this is scored →

Molly as informed peer 3.0 Guest teaching 5.3 Guest disagreement 2.0 Molly pushing back 1.3
05100:0010:0020:0030:001:45–5:51 · Molly as informed peer 2/10 Nucleus IQ Announcement and Live Platform Walkthrough Molly invites Kian to walk through the newly launched Nucleus IQ platform. Kian gives a live product demo, clarifying that polygenic scores measure genetic propensity rather than deterministic IQ outcomes.5:51–11:10 · Molly as informed peer 4/10 Addressing Genetic Ethics, Gatekeeping, and Disease Risk Nuance Molly raises critiques from MIT and Harvard researchers and asks Kian to explain his high genetic schizophrenia risk score. Kian attacks institutional paternalism in medicine and explains the crucial distinction between high relative genetic percentile risk and low absolute overall disease risk.11:10–14:27 · Molly as informed peer 3/10 Differentiating IQ, Intelligence, and Environmental Factors Molly inquires about the distinction between cognitive training apps, IQ testing, and raw intelligence. Kian details the 50/50 genetic versus environmental breakdown of intelligence, explaining why genetic models will always feature error bars.14:27–37:48 · Molly as informed peer 3/10 Sponsor Showcase: Archer Aviation Electric Air Taxis After an Archer sponsor break, Molly explores the history of consumer genomics, the drop in sequencing costs from ten million dollars to 399 dollars, business models, and founder origins. Molly gently probes whether consumer interest in preventative diagnostics is truly expanding beyond COVID highs.1:45–5:51 · Guest teaching 4/10 Nucleus IQ Announcement and Live Platform Walkthrough Molly invites Kian to walk through the newly launched Nucleus IQ platform. Kian gives a live product demo, clarifying that polygenic scores measure genetic propensity rather than deterministic IQ outcomes.5:51–11:10 · Guest teaching 6/10 Addressing Genetic Ethics, Gatekeeping, and Disease Risk Nuance Molly raises critiques from MIT and Harvard researchers and asks Kian to explain his high genetic schizophrenia risk score. Kian attacks institutional paternalism in medicine and explains the crucial distinction between high relative genetic percentile risk and low absolute overall disease risk.11:10–14:27 · Guest teaching 6/10 Differentiating IQ, Intelligence, and Environmental Factors Molly inquires about the distinction between cognitive training apps, IQ testing, and raw intelligence. Kian details the 50/50 genetic versus environmental breakdown of intelligence, explaining why genetic models will always feature error bars.14:27–37:48 · Guest teaching 5/10 Sponsor Showcase: Archer Aviation Electric Air Taxis After an Archer sponsor break, Molly explores the history of consumer genomics, the drop in sequencing costs from ten million dollars to 399 dollars, business models, and founder origins. Molly gently probes whether consumer interest in preventative diagnostics is truly expanding beyond COVID highs.1:45–5:51 · Guest disagreement 1/10 Nucleus IQ Announcement and Live Platform Walkthrough Molly invites Kian to walk through the newly launched Nucleus IQ platform. Kian gives a live product demo, clarifying that polygenic scores measure genetic propensity rather than deterministic IQ outcomes.5:51–11:10 · Guest disagreement 4/10 Addressing Genetic Ethics, Gatekeeping, and Disease Risk Nuance Molly raises critiques from MIT and Harvard researchers and asks Kian to explain his high genetic schizophrenia risk score. Kian attacks institutional paternalism in medicine and explains the crucial distinction between high relative genetic percentile risk and low absolute overall disease risk.11:10–14:27 · Guest disagreement 2/10 Differentiating IQ, Intelligence, and Environmental Factors Molly inquires about the distinction between cognitive training apps, IQ testing, and raw intelligence. Kian details the 50/50 genetic versus environmental breakdown of intelligence, explaining why genetic models will always feature error bars.14:27–37:48 · Guest disagreement 1/10 Sponsor Showcase: Archer Aviation Electric Air Taxis After an Archer sponsor break, Molly explores the history of consumer genomics, the drop in sequencing costs from ten million dollars to 399 dollars, business models, and founder origins. Molly gently probes whether consumer interest in preventative diagnostics is truly expanding beyond COVID highs.1:45–5:51 · Molly pushing back 0/10 Nucleus IQ Announcement and Live Platform Walkthrough Molly invites Kian to walk through the newly launched Nucleus IQ platform. Kian gives a live product demo, clarifying that polygenic scores measure genetic propensity rather than deterministic IQ outcomes.5:51–11:10 · Molly pushing back 2/10 Addressing Genetic Ethics, Gatekeeping, and Disease Risk Nuance Molly raises critiques from MIT and Harvard researchers and asks Kian to explain his high genetic schizophrenia risk score. Kian attacks institutional paternalism in medicine and explains the crucial distinction between high relative genetic percentile risk and low absolute overall disease risk.11:10–14:27 · Molly pushing back 1/10 Differentiating IQ, Intelligence, and Environmental Factors Molly inquires about the distinction between cognitive training apps, IQ testing, and raw intelligence. Kian details the 50/50 genetic versus environmental breakdown of intelligence, explaining why genetic models will always feature error bars.14:27–37:48 · Molly pushing back 2/10 Sponsor Showcase: Archer Aviation Electric Air Taxis After an Archer sponsor break, Molly explores the history of consumer genomics, the drop in sequencing costs from ten million dollars to 399 dollars, business models, and founder origins. Molly gently probes whether consumer interest in preventative diagnostics is truly expanding beyond COVID highs.

speaking balance: gold is Molly, purple is the guest (3 minute bins)

0:00 · Molly 42.9% · guest 57.1%0:00 · Molly 42.9% · guest 57.1%3:00 · Molly 1.7% · guest 98.3%3:00 · Molly 1.7% · guest 98.3%6:00 · Molly 15.9% · guest 84.1%6:00 · Molly 15.9% · guest 84.1%9:00 · Molly 33.9% · guest 66.1%9:00 · Molly 33.9% · guest 66.1%12:00 · Molly 26.7% · guest 73.3%12:00 · Molly 26.7% · guest 73.3%15:00 · Molly 22.6% · guest 77.4%15:00 · Molly 22.6% · guest 77.4%18:00 · Molly 21.7% · guest 78.3%18:00 · Molly 21.7% · guest 78.3%21:00 · Molly 15.9% · guest 84.1%21:00 · Molly 15.9% · guest 84.1%24:00 · Molly 8% · guest 92%24:00 · Molly 8% · guest 92%27:00 · Molly 24.2% · guest 75.8%27:00 · Molly 24.2% · guest 75.8%30:00 · Molly 16.5% · guest 83.5%30:00 · Molly 16.5% · guest 83.5%33:00 · Molly 16% · guest 84%33:00 · Molly 16% · guest 84%36:00 · Molly 34.5% · guest 65.5%36:00 · Molly 34.5% · guest 65.5%
Sharpest disagreement ▶ 6:35 Denouncing paternalistic medical gatekeepers

Kian forcefully pushes back against ethicists and regulatory bureaucrats who restrict public access to genetic data, calling their paternalism harmful gatekeeping.

 Hardest push from Molly ▶ 22:23 Challenging the premise of durable consumer health adoption

Molly interrupts the founder pitch to press Kian on whether real consumer adoption is accelerating or if pandemic-era heightened awareness is fading away.

 Biggest teaching moment ▶ 12:25 Dispelling deterministic genetic intelligence myths

Kian educates the host on the scientific reality that half of intelligence is environmental, proving that whole genome analysis can never deterministically output a fixed IQ number.

 Molly holds their own ▶ 7:15 Citing academic pushback from MIT and Harvard

Molly demonstrates industry research depth by citing specific critical publications from elite academic researchers targeting Nucleus's methodology.
the scores for every segment, with the reasoning behind each
ChapterTopicMolly as informed peerGuest teachingGuest disagreementMolly pushing backWhy
Nucleus IQ Announcement and Live Platform Walkthrough 2410 Molly invites Kian to walk through the newly launched Nucleus IQ platform. Kian gives a live product demo, clarifying that polygenic scores measure genetic propensity rather than deterministic IQ outcomes.
Addressing Genetic Ethics, Gatekeeping, and Disease Risk Nuance 4642 Molly raises critiques from MIT and Harvard researchers and asks Kian to explain his high genetic schizophrenia risk score. Kian attacks institutional paternalism in medicine and explains the crucial distinction between high relative genetic percentile risk and low absolute overall disease risk.
Differentiating IQ, Intelligence, and Environmental Factors 3621 Molly inquires about the distinction between cognitive training apps, IQ testing, and raw intelligence. Kian details the 50/50 genetic versus environmental breakdown of intelligence, explaining why genetic models will always feature error bars.
Sponsor Showcase: Archer Aviation Electric Air Taxis 3512 After an Archer sponsor break, Molly explores the history of consumer genomics, the drop in sequencing costs from ten million dollars to 399 dollars, business models, and founder origins. Molly gently probes whether consumer interest in preventative diagnostics is truly expanding beyond COVID highs.

Statements from this episode (8)

Assertion Supported
Sadeghi: Nucleus IQ benchmarks against genetic cohorts, rather than predicting IQ
“Nucleus IQ, the function of it is not to predict your IQ score. The way it works is it basically tells you people with similar genetics to you, how they tend to score on an IQ test.”
Kian Sadeghi Aug 16, 2024 ▶ 3:30
Assertion Supported
Sadeghi: Scientific research already links genetics directly to intelligence
“At the frontier of science, we do already have associations with genetics and intelligence, and we really believe in giving these insights to customers.”
Kian Sadeghi Aug 16, 2024 ▶ 5:01
Disclosure
Sadeghi shares his 99.3 percentile schizophrenia genetic risk and 1.43% overall risk
“And you can see here how, even though I'm dramatically higher genetic risk, right? 2.48, I think is in the 99.3 percentile. My overall risk is 1.43%.”
Kian Sadeghi Aug 16, 2024 ▶ 10:13
Assertion Supported
Sadeghi: Genetics alone can never predict IQ due to 50% environmental factor
“You can't. From genetics predicts someone's IQ. And actually what a lot of people don't realize is you will never be able to. And the reason for that is because 50% of intelligence is environmental. The other 50% is genetic.”
Kian Sadeghi Aug 16, 2024 ▶ 13:01
Assertion Supported
Sadeghi: Whole genome sequencing cost $10M per sample in 2006
“23 me, the cost of actually sequencing all of someone's DNA, you know, getting the entire read of it, not a small fraction, all of it was around ten million dollars per sample.”
Kian Sadeghi Aug 16, 2024 ▶ 16:01
Prediction Not checkable as stated
Sadeghi predicts a trillion-dollar platform integrating all personal health data
“I think we're in the age where there will be a trillion dollar consumer healthcare business, and that business is going to be integrated in the entirety of someone's health data on the platform.”
Kian Sadeghi Aug 16, 2024 ▶ 20:28
Prediction Didn’t hold up
Sadeghi predicts Nucleus will sequence 500,000 whole genomes by 2026
“I think we can actually, I think two years from now, we can get half a million samples. Two years from today, I think we could do that.”
Kian Sadeghi Aug 16, 2024 ▶ 29:11
Disclosure
Nucleus Genomics employs 14 people full-time
“We're only 14 people full-time.”
Kian Sadeghi Aug 16, 2024 ▶ 34:07
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 160 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more